To hear about similar clinical trials, please enter your email below
Trial Title:
Magnetic Resonance Imaging of Breast Cancer
NCT ID:
NCT01035112
Condition:
Breast Cancer
Breast Cancer Non-invasive Breast Cancer
Conditions: Official terms:
Breast Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Diagnostic
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
MRI
Arm group label:
Magnetic Resonance Imaging (MRI) of Breast Cancer
Summary:
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging
techniques to determine which method best finds and defines breast cancer.
Criteria for eligibility:
Criteria:
INCLUSION CRITERIA
- Female
- Documented breast physical examination,
- Documented mammography within 3 months of the MR studies
- Palpable or mammographically-detected suspect breast lesions
- Women who have already undergone lumpectomy for breast cancer and have
post-biopsy/post-radiation changes will be eligible if they have
mammographically-detected or palpable breast abnormalities which are sufficiently
suspicious to merit core needle or surgical biopsy.
EXCLUSION CRITERIA:
- Male by birth
- Able to complete the MR examination. Subjects will be interviewed by one of the
investigators for the usual contraindications to
- MR contraindications including
- Pacemakers
- Metallic implants
- Severe claustrophobia
- Aneurysm clips
- Pregnancy
- Current lactation
- Other conditions precluding proximity to a strong magnetic field.
- Received an enhanced MR procedure within 48 hours,
- Iodinated contrast within six hours,
- Known sensitivity to MR contrast agents,
- Not likely to complete the study in full or
- Other clinical reason which would preclude participation in the protocol.
Gender:
Female
Gender based:
Yes
Gender description:
female by birth
Minimum age:
21 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Stanford University School of Medicine
Address:
City:
Stanford
Zip:
94305
Country:
United States
Status:
Recruiting
Contact:
Last name:
Jocelyn Steffen
Phone:
650-725-1812
Email:
jsteffen@stanford.edu
Investigator:
Last name:
Bruce Lewis Daniel
Email:
Principal Investigator
Investigator:
Last name:
Brian Andrew Hargreaves
Email:
Sub-Investigator
Investigator:
Last name:
Robert J Herfkens
Email:
Sub-Investigator
Start date:
April 1, 1995
Completion date:
May 2027
Lead sponsor:
Agency:
Stanford University
Agency class:
Other
Collaborator:
Agency:
National Institutes of Health (NIH)
Agency class:
NIH
Source:
Stanford University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01035112
